2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
Industries:
Location:
Key people:
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
Key people:
- Marvin Gee ******.***@3tbiosciences.com
- Luke Lee ****.***@ihcfunds.com
- Leah Sibener twitter
5
Funding Rounds
$82.8m
Money raised
Peptome is a London-based protein physics intelligence company founded in 2016 by Kamil Tamiola and Matt Heberling. It utilizes artificial intelligence for computers to process all information about protein data in the same efficient way that scientists do.
Industries:
Location:
Key people:
- Matthew Heberling ****@run-form.com
- Kamil Tamiola *****.*******@peptone.io
2
Funding Rounds
$1.0b
Money raised
RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.
1
Funding Rounds
$16.0m
Money raised
A pharmaceutical company that develops topical products to treat rare diseases
Industries:
Location:
Key people:
2
Funding Rounds
$22.7m
Money raised
FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs.
Industries:
Location:
Key people:
3
Funding Rounds
$121.0m
Money raised
Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.
2
Funding Rounds
$44.0m
Money raised
BC Platforms provide data management systems for clinical and genomic research, pharmacogenomics research, preventive and personalized medicine, and biobanking.
4
Funding Rounds
$313.0m
Money raised
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
7
Funding Rounds
$210.5m
Money raised
Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.
Industries:
Location:
8
Funding Rounds
$3.4m
Money raised
Bloom Biorenewables is making biomass a true alternative to petroleum.
7
Funding Rounds
$24.5m
Money raised
Immunophotonics is a company developing immunotherapy-based treatments for cancer founded in 2012 by Lu Alleruzzo.
2
Funding Rounds
$13.0m
Money raised
Molecule is a decentralized biotech protocol, building a web3 marketplace for research-related IP.
Location:
6
Funding Rounds
$15.8m
Money raised
Scailyte is a drug discovery and molecular diagnostics company developing molecular analytical tools for clinical applications.
Industries:
Location:
Key people:
2
Funding Rounds
$2.0m
Money raised
Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.
Location:
Key people:
- Riccardo Dainese ********@alitheagenomics.com
- Daniel Alpern *******@alitheagenomics.com
- Bart Deplancke linkedin
1
Funding Rounds
$150.0m
Money raised
Neurimmune AG is a Schlieren, Zurich-based pharmaceutical company
Location:
Key people:
1
Funding Rounds
$20.0m
Money raised
Cellestia is a bio-pharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
Industries:
Location:
Key people:
3
Funding Rounds
$33.5m
Money raised
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
Industries:
Location:
Key people:
3
Funding Rounds
$317.0m
Money raised
Treatment developer for central nervous system (CNS) disorders patient.
Industries:
Location:
6
Funding Rounds
$715.6k
Money raised
Regenhu Limited is a biotechnology company that aims to develop bioprinting technologies that will positively impact many medical fields.
Industries:
Location:
Key people:
2
Funding Rounds
$48.0m
Money raised
Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.
1
Funding Rounds
$16.9m
Money raised
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.
Industries:
Location:
Key people:
- Matthias Steger linkedin
- Christian Angermayer *********.**********@apeiron-investments.com
- Manuel Serrano
1
Funding Rounds
$11.1m
Money raised
A pharmaceutical company specializing in developing treatments for rare diseases
Industries:
Location:
2
Funding Rounds
$434.0m
Money raised
Rakuten Aspyrian is developing tumor-targeted precision therapies based on its proprietary platform Photoimmunotherapy.
Industries:
Location:
4
Funding Rounds
$2.1m
Money raised
PharmaBiome is a microbiome company.
6
Funding Rounds
$6.2m
Money raised
Proprietary technology platform for the design and selection of GPCR-targeting compounds
Industries:
Location:
Key people:
2
Funding Rounds
$25.0m
Money raised
Stalicla is a Geneva-based company developing a drug development platform for neurodevelopmental disorders.
Industries:
Location:
2
Funding Rounds
$42.0m
Money raised
NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.
Industries:
Location:
3
Funding Rounds
$400.0m
Money raised
Cell and Immunotherapy (SCIP) platform.
Industries:
Location:
1
Funding Rounds
$546.2k
Money raised
Gene Predictis is a Switzerland based biotechnology company that was founded in 2004
Industries:
Location:
4
Funding Rounds
$120.5m
Money raised
NousCom is a viral vector-based cancer vaccines developer founded in 2015.
Industries:
Location:
1
Funding Rounds
$20.8m
Money raised
AB2 Bio is a Lausanne-based medical diagnostics company involved in drug discovery and development for therapeutic solutions for inflammatory diseases founded in 2010 by Barthelemy Helg.
Industries:
Location:
Key people:
4
Funding Rounds
$24.1m
Money raised
Versameb is a Basel-based biotechnology company focusing on discovering and developing RNA-based drugs for modulation of protein expression.
Industries:
Location:
6
Funding Rounds
Vaccines
Industries:
Location:
Key people:
1
Funding Rounds
$3.0m
Money raised
Analytical testing company focused on improving people's health.
Industries:
Location:
3
Funding Rounds
$78.1m
Money raised
Ariceum Therapeutics is developing novel drugs for systemic targeted radiation therapy.
Industries:
Location:
1
Funding Rounds
$1.2m
Money raised
Novigenix is a Épalinges-based molecular diagnostics company developing blood tests for early detection of cancer founded in 2014.
Location:
1
Funding Rounds
$7.0m
Money raised
Leman Biotech is an AI-enabled metabolic cancer immunotherapy founded in 2021.
Industries:
Location:
1
Funding Rounds
$8.9m
Money raised
Life science company focused on developing therapeutic nutrition products through research and clinical science.
Industries:
Location:
2
Funding Rounds
$98.0m
Money raised
Glycanengineering platform.
Industries:
Location:
1
Funding Rounds
$55.0m
Money raised
NousCom is a cancer Immunotherapies founded in 2015.
Industries:
Location:
2
Funding Rounds
$25.0m
Money raised
Biotechnology platform developing therapies by investing in people and ideas.
Location:
2
Funding Rounds
$100.0m
Money raised
Therachon is a company founded in 2014.
Industries:
Location:
1
Funding Rounds
$11.7m
Money raised
Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .
Industries:
Location:
Key people:
- Ulrich Siler ******.*****@somagenetix.com
- Janine Reichenbach ******.***********@somagenetix.com
1
Funding Rounds
$27.5m
Money raised
Azafaros is a small Molecules.
Industries:
Location:
1
Funding Rounds
$1.1m
Money raised
Laeverdoc is a Switzerland-based company.